In a retrospective study conducted in the United Kingdom, data were presented on OHSS cases in high-risk women following ovulation induction with rhCG, GnRH agonist, and kisspeptins [96]. This evidence concerns the gene KISS1 and ovarian hyperstimulation syndrome.